Generate a tailored SOP for Dr. Erin Hofstatter. Improve your application with a focused, well-structured draft.
Dr. Erin Hofstatter is a medical oncologist with clinical research expertise focused on breast cancer and its genetics. She consults patients at the Breast Cancer Prevention Clinic, particularly those at increased risk for breast cancer due to hereditary factors or strong family histories. As the Co-Director of the Smilow Cancer Genetics Prevention Program at Yale, Dr. Hofstatter has significantly grown the clinical genetic counseling service, now serving around 2000 patients annually across multiple sites in Connecticut. Her clinical work informs her research on breast cancer treatment and prevention, particularly for high-risk patients with genetic mutations. She has developed skills in clinical trial design and translational research, and serves as a Principal Investigator in national cooperative group trials, contributing to important research initiatives in BRCA+ breast cancer and DCIS triple-negative breast cancer. Dr. Hofstatter has also focused her efforts on examining epigenetic signatures related to breast cancer risk and the aging of normal breast tissue.
Smilow Cancer Genetics Prevention Program • New Haven, CT
Leads efforts in the clinical genetic counseling service to support breast cancer prevention.
National Cooperative Group Trials • New Haven, CT
Conducts research on BRCA+ breast cancer and develops clinical trials.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.